LSUHSC researcher discovers target for new Rx class for inflammatory disorders
2013-10-03
(Press-News.org) New Orleans, LA – Research led by Charles Nichols, PhD, Associate Professor of Pharmacology at LSU Health Sciences Center New Orleans, describes a powerful new anti-inflammatory mechanism that could lead to the development of new oral medications for atherosclerosis and inflammatory bowel disorders (IBS). The findings are published in PLOS ONE, available online at http://dx.plos.org/10.1371/journal.pone.0075426
One of the master inflammatory molecules in the body is Tumor Necrosis Factor-alpha (TNF-alpha). Infections and certain diseases lead to the production of this molecule, which then stimulates an immune response. Diseases like atherosclerosis, rheumatoid arthritis, and IBS are believed to have inflammation influenced by TNF-alpha as a primary component. Unfortunately, there are no convenient therapeutics to treat inflammation caused by TNF-alpha. Current therapies directed at blocking TNF-alpha inflammation are very expensive antibody treatments that are administered in the clinic.
The research team found that activation of serotonin 5-HT2A receptor proteins potently blocks TNF-alpha induced inflammation. The serotonin 5-HT2A receptor is the main target of classic hallucinogenic drugs like LSD, and the drug the researchers used to activate the receptor protein is itself a member of this class. In the study, the researchers activated serotonin 5-HT2A receptors, and then administered TNF-alpha to mice to produce an inflammatory response. In mice when 5-HT2A receptors were activated before TNF-alpha was administered, there was a near complete blockade of inflammation compared to mice where the 5-HT2A receptors were not activated that had a full inflammatory response. The effects were most powerful in vascular tissues like the aorta, and the intestine. In the intestine, inflammation was blocked with an extremely low dose of the drug – 300 times lower than required for any behavioral effects of the drug.
"Our results potentially represent a breakthrough of a new first in class orally available small molecule-based therapeutic strategy to treat inflammatory diseases involving TNF-alpha," notes Charles Nichols, PhD, Associate Professor of Pharmacology at LSU Health Sciences Center New Orleans. "Although the serotonin 5-HT2A receptor is the primary target for certain drugs, including LSD, to mediate their behavioral effects, the dose of drug necessary for anti-inflammatory effects is orders of magnitude lower than intoxicating doses, and future therapies may target directly the relevant cellular processes activated by the 5-HT2A receptor rather than the receptor itself."
###
Atherosclerosis, known as hardening of the arteries, is a major cause of coronary heart disease, which is the #1 killer of both men and women in the United States.
According to the National Institute of Diabetes and Digestive and Kidney Diseases, irritable bowel syndrome is estimated to affect 3 to 20 percent of the population, with most studies ranging from 10 to 15 percent. However, less than one-third of people with the condition see a health care provider for diagnosis. IBS affects about twice as many women as men and is most often found in people younger than 45 years.
The LSUHSC research team also included Felix Nau, Jr., Bangning Yu, and David A. Martin. The project was supported by a grant ( R21HL095961) from the National Heart, Lung, Blood Institute of the National Institutes of Health.
LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's academic health leader, LSUHSC consists of a School of Medicine, the state's only School of Dentistry, Louisiana's only public School of Public Health, the only School of Nursing within an academic health center in Louisiana, and Schools of Allied Health Professions, and Graduate Studies. LSUHSC faculty members take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSUHSC research enterprise generates jobs and enormous economic impact. LSUHSC faculty members have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu and http://www.twitter.com/LSUHSCHealth
ELSE PRESS RELEASES FROM THIS DATE:
Stem cells help repair traumatic brain injury by building a 'biobridge'
2013-10-03
Tampa, FL (Oct. 3, 2013) -- University of South Florida researchers have suggested a new view of how stem cells may help repair the brain following trauma. In a series of preclinical experiments, they report that transplanted cells appear to build a "biobridge" that links an uninjured brain site where new neural stem cells are born with the damaged region of the brain.
Their findings were recently reported online in the peer-reviewed journal PLOS ONE.
"The transplanted stem cells serve as migratory cues for the brain's own neurogenic cells, guiding the exodus of these ...
American Chemical Society podcast: A one-two punch against cancer
2013-10-03
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes the development and successful lab tests on the first potential drug to pack a lethal one-two punch against melanoma skin cancer cells.
Based on a report by Nathan Luedtke, Ph.D., in the journal ACS Chemical Biology, the new podcast is available without charge at iTunes and from http://www.acs.org/globalchallenges.
The drug has a dual activity. Hit number one destroys cells in the main tumor, and the second hit blocks the spread ...
Scientists discover new role for cell dark matter in genome integrity
2013-10-03
This news release is available in French. University of Montreal researchers have discovered how telomerase, a molecule essential for cancer development, is directed to structures on our genome called telomeres in order to maintain its integrity and in turn, the integrity of the genome. In an article published in the journal Molecular Cell, the scientists explain how they discovered that telomerase molecules are rallied together by a molecule called TERRA, a so-called "non-coding RNA" having no known function in the cell. The scientists used cutting edge microscopy ...
2 new enigmatic spider species with peculiar living habits from Uruguay
2013-10-03
The two new species described from Uruguay, Chaco castanea and Chaco costai, are middle sized spiders that range between 1 and 2 cm in body size. Like all Nemesiids they have elongated body and robust legs with predominantly black-brownish coloration. A recent study in the open access journal Zookeys provides a detailed description of the two news species and a rare glimpse into their living habits.
The two new species are typically found in sandy soils of oceanic and river coastal
areas associated with psammophyte, or sand-dwelling, vegetation. This is where these peculiar ...
Scientists generate first map of clouds on an exoplane
2013-10-03
CAMBRIDGE, Mass. — On the exoplanet Kepler 7b, the weather is highly predictable, an international team of scientists has found: On any given day, the exoplanet, which orbits a star nearly 1,000 light-years from Earth, is heavily overcast on one side, while the other side likely enjoys clear, cloudless weather.
The new work, by researchers from MIT and other institutions, is the first mapping of the distribution of clouds on an exoplanet. The scientists observed that one of Kepler 7b's hemispheres is blanketed with a dense layer of clouds — far denser than any found ...
New X-ray vision can reveal internal structure of objects
2013-10-03
Scientists have developed a new kind of 'X-ray vision' that is able to peer inside an object and map the three-dimensional distribution of its nano-properties in real time.
University of Manchester researchers, working with colleagues in the UK, Europe and the US, say the novel imaging technique could have a wide range of applications across many disciplines, such as materials science, geology, environmental science and medical research.
"This new imaging method – termed Pair Distribution Function-Computed Tomography – represents one of the most significant developments ...
Louisiana Tech University physicists contribute to new findings of international research team
2013-10-03
RUSTON, La. – Physicists from Louisiana Tech University are part of an international team of researchers which has reported first results for the proton's weak charge based on precise new data from Jefferson Laboratory, the nation's premier electron beam facility for nuclear and particle physics research in Newport News, Va.
The results will be published in an upcoming issue of "Physical Review Letters," a prestigious and widely-referenced international journal that focuses on major advances in physics and cross disciplinary developments.
The "Q-weak" experiment used ...
Three hours is enough to help prevent mental health issues in teens
2013-10-03
This news release is available in French. The incidence of mental health issues amongst 509 British youth was reduced by 25 to 33% over the 24 months following two 90-minute group therapy sessions, according to a study led by Dr. Patricia Conrod of the University of Montreal and its affiliated Sainte-Justine Hospital Research Centre. "Almost one-in-four American 8 to 15 year olds has experienced a mental health disorder over the past year. We know that these disorders are associated with a plethora of negative consequences," Conrod said. "Our study shows that teacher ...
Drowsy Drosophila shed light on sleep and hunger
2013-10-03
Why does hunger keep us awake and a full belly make us tired? Why do people with sleep disorders such as insomnia often binge eat late at night? What can sleep patterns tell us about obesity?
Sleep, hunger and metabolism are closely related, but scientists are still struggling to understand how they interact. Now, Brandeis University researchers have discovered a function in a molecule in fruit flies that may provide insight into the complicated relationship between sleep and food.
In the October issue of the journal Neuron, Brandeis scientists report that sNPF, a ...
New small-molecule catalyst does the work of many enzymes
2013-10-03
CHAMPAIGN, Ill. — Researchers report that they have created a man-made catalyst that is an "enzyme mimic." Unlike most enzymes, which act on a single target, the new catalyst can alter the chemical profiles of numerous types of small molecules. The catalyst – and others like it – will greatly speed the process of drug discovery, the researchers say.
Their findings appear in the Journal of the American Chemistry Society.
Most enzymes are large proteins that act on only one molecular target, said University of Illinois chemistry professor M. Christina White, who conducted ...